Skip to main content
. 2009 Jun 9;3:17. doi: 10.1186/1753-2000-3-17

Table 5.

TEAEs Leading to Discontinuation by System Organ Class and Preferred Term (All Occurrences: Safety Population, N = 129)

System Organ Class Preferred Term n (%)
Gastrointestinal 4 (3.1)

Abdominal pain 2 (1.6)

Diarrhea 1 (0.8)

Nausea 2 (1.6)

Vomiting 2 (1.6)

General 4 (3.1)

Fatigue 2 (1.6)

Irritability 2 (1.6)

Investigations 1 (0.8)

Weight decrease 1 (0.8)

Metabolic/nutritional 3 (2.3)

Anorexia 2 (1.6)

Decreased appetite 1 (0.8)

Nervous system 2 (1.6)

Amnesia 1 (0.8)

Psychomotor hyperactivity 2 (1.6)

Tardive dyskinesia
(lip-smacking)
1 (0.8)

Psychiatric 5 (3.9)

Insomnia/sleep disorder 4 (3.1)

Suicidal ideation 1 (0.8)

Tearfulness 1 (0.8)

TEAEs: treatment-emergent adverse events